Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

The in vitro and in vivo treatment effects of overexpressed lentiviral vector-mediated human BMP2 gene in the femoral bone marrow stromal cells of osteoporotic rats.

Zhao B, Wang Q, Tao T, Li J, Lin Q.

Int J Mol Med. 2013 Dec;32(6):1355-65. doi: 10.3892/ijmm.2013.1507. Epub 2013 Sep 25.

PMID:
24068163
2.

Adenoviral-mediated gene transfer into bone marrow: an effective surgical technique in rat.

Rodriguez-Lecompte JC, Romero-Perez GA, Ramirez-Yañez G, Ask K, Gauldie J.

Eur Surg Res. 2013;50(3-4):282-91. doi: 10.1159/000351336. Epub 2013 Jun 18.

3.

Epigenetic regulation during fetal femur development: DNA methylation matters.

de Andrés MC, Kingham E, Imagawa K, Gonzalez A, Roach HI, Wilson DI, Oreffo RO.

PLoS One. 2013;8(1):e54957. doi: 10.1371/journal.pone.0054957. Epub 2013 Jan 28.

4.

Treatment of osteonecrosis of the femoral head with VEGF165 transgenic bone marrow mesenchymal stem cells in mongrel dogs.

Hang D, Wang Q, Guo C, Chen Z, Yan Z.

Cells Tissues Organs. 2012;195(6):495-506. doi: 10.1159/000329502. Epub 2011 Nov 2.

PMID:
22056983
5.

Lentiviral-mediated integrin α5 expression in human adult mesenchymal stromal cells promotes bone repair in mouse cranial and long-bone defects.

Srouji S, Ben-David D, Fromigué O, Vaudin P, Kuhn G, Müller R, Livne E, Marie PJ.

Hum Gene Ther. 2012 Feb;23(2):167-72. doi: 10.1089/hum.2011.059. Epub 2011 Dec 2.

PMID:
21958321
6.

In vivo gene delivery into hCD34+ cells in a humanized mouse model.

Frecha C, Fusil F, Cosset FL, Verhoeyen E.

Methods Mol Biol. 2011;737:367-90. doi: 10.1007/978-1-61779-095-9_15.

PMID:
21590405
7.

Emerging ideas: treatment of precollapse osteonecrosis using stem cells and growth factors.

Cui Q, Botchwey EA.

Clin Orthop Relat Res. 2011 Sep;469(9):2665-9. doi: 10.1007/s11999-010-1738-1. Epub 2010 Dec 16.

8.

The healing of critical-sized femoral segmental bone defects in rabbits using baculovirus-engineered mesenchymal stem cells.

Lin CY, Chang YH, Lin KJ, Yen TC, Tai CL, Chen CY, Lo WH, Hsiao IT, Hu YC.

Biomaterials. 2010 Apr;31(12):3222-30. doi: 10.1016/j.biomaterials.2010.01.030. Epub 2010 Feb 9.

PMID:
20144476
9.

Treatment of avascular necrosis of the femoral head by hepatocyte growth factor-transgenic bone marrow stromal stem cells.

Wen Q, Ma L, Chen YP, Yang L, Luo W, Wang XN.

Gene Ther. 2008 Dec;15(23):1523-35. doi: 10.1038/gt.2008.110. Epub 2008 Jul 17.

PMID:
18633448
10.

Treatment of osteonecrosis of the femoral head with hBMP-2-gene-modified tissue-engineered bone in goats.

Tang TT, Lu B, Yue B, Xie XH, Xie YZ, Dai KR, Lu JX, Lou JR.

J Bone Joint Surg Br. 2007 Jan;89(1):127-9. Erratum in: J Bone Joint Surg Br. 2007 Mar;89(3):421.

11.

Use of genetically engineered bone-marrow stem cells to treat femoral defects: an experimental study.

Cui Q, Xiao Z, Li X, Saleh KJ, Balian G.

J Bone Joint Surg Am. 2006 Nov;88 Suppl 3:167-72.

PMID:
17079384
12.

BMP2 gene therapy on the repair of bone defects of aged rats.

Yue B, Lu B, Dai KR, Zhang XL, Yu CF, Lou JR, Tang TT.

Calcif Tissue Int. 2005 Dec;77(6):395-403. Epub 2005 Dec 5.

PMID:
16362458
13.
14.

Enhanced osteoinduction by mesenchymal stem cells transfected with a fiber-mutant adenoviral BMP2 gene.

Tsuda H, Wada T, Yamashita T, Hamada H.

J Gene Med. 2005 Oct;7(10):1322-34.

PMID:
15926193
15.

Engineered allogeneic mesenchymal stem cells repair femoral segmental defect in rats.

Tsuchida H, Hashimoto J, Crawford E, Manske P, Lou J.

J Orthop Res. 2003 Jan;21(1):44-53.

PMID:
12507579
16.

Multiple cellular phenotypes in an insertional mutation in mouse affecting bone development.

Nadon NL, Doersen CJ, Lade DA, Medina K, Thompson L, Rohrer M, Gimble JM.

Calcif Tissue Int. 2000 Dec;67(6):449-54.

PMID:
11289693
17.
18.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk